PH

Pichai Hussain Mohammed Yusuff

Active Director Director DIN 10396714
DIN 10396714 First appointment Nov 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Pichai Hussain Mohammed Yusuff

Data last updated:

Pichai Hussain Mohammed Yusuff is a Director at Glabio Pharma Private Limited (since 2023).

DIN 10396714
Primary Designation Director
First Appointment 19 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glabio Pharma Private Limited U46497TZ2023PTC029946
Director19 Nov 20232023Active

Board colleagues of Pichai Hussain Mohammed Yusuff

Directorship timeline

Open interactive timeline →
Glabio Pharma Private Limited
Premium access

Shareholding and investment profile for Pichai Hussain Mohammed Yusuff

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pichai Hussain Mohammed Yusuff

Pichai Hussain Mohammed Yusuff currently holds 1 directorship: Glabio Pharma Private Limited (Director, since 19 Nov 2023).

Pichai Hussain Mohammed Yusuff was first appointed on 19 Nov 2023 as Director at Glabio Pharma Private Limited.

The current boards of Pichai Hussain Mohammed Yusuff's companies include Mohanan Akil (Glabio Pharma Private Limited), Moideen Haja Hussain Jainudeen (Glabio Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available